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Abstract
Background Roughly 23% of breast conserving surgery (BCS) patients undergo a second re-excision procedure due to 
pathologically positive surgical margins. We investigated the feasibility and potential value of micro-Computed Tomography 
(micro-CT) as a surgical margin guidance tool during BCS.
Methods A cohort of 32 BCS specimens was prospectively imaged with a pre-clinical micro-CT system upon arrival in 
the surgical pathology laboratory. Reconstructed micro-CT scans were evaluated retrospectively by an experienced breast 
radiologist, who provided binary determinations whether lesions extended to the specimen margin. These readings were 
then compared to the final pathological diagnosis and to 2D specimen radiography readings.
Results Of the 32 specimens imaged, 28 had malignant and four had benign pathological diagnoses. Overall five (four 
malignant, one benign) of the 32 specimens had lesion tissue extending to the margin. For all 32 specimens, micro-CT recon-
structions were calculated (< 4 min. acquisition + reconstruction time) and each specimen was volumetrically analyzed by a 
radiologist. Of the 28 malignant specimen readings, 18 matched the final pathological diagnosis [64%, 95 CI (47%–81%)], 
with a negative predictive value of 89% [95 CI (74%–96%)]. Micro-CT readings revealed changes in the tumor location and 
margin status as compared to single-projection radiography readings.
Conclusions Micro-CT scanning of BCS specimens enabled margin status assessment over the entirety of the surgical surface 
in a clinically relevant time frame, provided additional spatial information over single-projection radiography, and may be 
a potentially useful BCS guidance tool.
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FCD  Fibrocystic disease
CSL  Complex sclerosing lesion
Background
Breast conserving surgery (BCS) in combination with 
radiotherapy has become standard-of-care for treatment of 
early stage breast cancer, offering equivalent survival to full 
mastectomy, but with a far less extensive surgical procedure 
[1]. However, this equivalency holds true only if resected 
specimens have negative margins [2, 3]. In non-palpable 
cancers, BCS guidance involves pre-operative wire place-
ment [4, 5] or radioactive seed tumor localization [6], often 
followed by specimen mammography [7, 8]. Yet, 20–40% 
of patients who undergo BCS require re-excision because of 
a pathologically positive or close margin [9]. Additionally, 
substantial variability exists among surgeons and institu-
tions, with a reported re-excision rates in the range of 0–70% 
and 1.7–20.9%, respectively [9, 10], highlighting the clinical 
need for better surgical guidance during BCS procedures.
The pre-clinical imaging technology, micro-Computed 
Tomography (micro-CT), offers three dimensional (3D) 
image reconstruction with sub-millimeter resolution but at 
much smaller fields of view than clinical CT. While this 
technology has been utilized extensively in pre-clinical 
specimen and animal studies [11–13], it has not been widely 
used to image surgically resected breast tissues [14]. Tang 
et al. have motivated the potential value of this technology 
in assessing shaved cavity margins [15] and they have also 
shown it to measure the largest tumor dimension in resected 
BCS specimens accurately [16]. However, the diagnostic 
value of micro-CT in assessing whole resected BCS speci-
mens has not been investigated. Accordingly, the feasibility 
and potential diagnostic value of micro-CT was evaluated 
as a surgical guidance tool for BCS by performing an initial 
correlation of micro-CT analysis to the final histopathologic 
diagnosis, and qualitatively comparing specimen micro-CT 
to single-projection specimen mammography.
Materials and methods
Overview of specimen imaging protocol
From May of 2017 to January of 2018, a cohort of 32 BCS 
specimens was imaged prospectively under a HIPPA com-
pliant, Institutional Review Board (IRB) approved observa-
tional protocol. Patients undergoing consented and elective 
BCS were considered for this study. After each specimen 
was surgically removed and inked to record its orientation 
[17], it was placed on a radiolucent grid (AccuGrid, Beekley 
Medical, Bristol, CT), sealed in a plastic bag, and underwent 
single-projection specimen mammography to confirm the 
primary lesion and surgical clip were removed from the 
patient. The sealed specimen was then sent to the Pathol-
ogy specimen grossing laboratory. Upon arrival, each speci-
men was removed from the plastic bag, then scanned with 
the micro-CT in the same orientation as single-projection 
specimen mammography, and subsequently returned to the 
pathologists’ assistant for standard gross analysis and histo-
logical processing. Only single-projection specimen mam-
mography was available for this study. Micro-CT scans were 
analyzed retrospectively by an experienced breast radiologist 
(R.A.Z) blinded to the pathological diagnosis. Participant 
consent was waived by the IRB because the study did not 
interfere with standard-of-care nor did it disclose or analyze 
protected health information (PHI).
Micro‑CT imaging device and reconstructions
Upon arrival in Pathology, specimens were compressed 
between two acrylic plates and imaged with a micro-CT 
scanner (IVIS SpectrumCT, PN 128,201, PerkinElmer, 
Hopkington, MA), which was physically located in the 
specimen grossing laboratory in order to minimize tissue 
handling time. Scanning was performed at X-ray settings 
of 50 kVp and 1 mA with a 440 µm aluminum filter. The 
X-ray source-detector pair was fixed, with a 50 µm focal spot 
size. The specimen was rotated through 360° and received a 
100 ms exposure at each 0.5° increment (72 s acquisition). 
Standard filtered back projection (FBP) was used to recon-
struct an image volume of 12 × 12 × 3 cm3 with 0.15 mm 
cubic voxels (~ 2 min. reconstruction time). The X-ray detec-
tor (3072 × 864 pixels) was binned down by a factor of 4 
(1024 × 216 pixels) in order to increase the signal to noise 
ratio (SNR) and decrease the total scan time. A previous 
publication reported the micro-CT to have a resolution of 
240 µm and an SNR of 34 for this acquisition setting [18]. 
While the system is capable of capturing a voxel size of 
40 µm, the exposure and reconstruction times would have to 
be increased to non-clinically relevant timescales if scanning 
the entire field of view. For selected scans, 3D visualization 
models were created using the “Volume Rendering” tool in 
3D Slicer (v4, https ://www.slice r.org) [19].
Pathological diagnosis
After micro-CT scanning, specimens were returned to the 
pathologists’ assistants, who performed standard-of-care 
gross analysis to determine both representative sections of 
lesional tissue as well as all areas of possible lesion involve-
ment with the specimen margin. These tissue sections under-
went standard histological processing to create hematoxy-
lin and eosin (H&E) stained slides, which were diagnosed 
by an experienced histopathologist (W.A.W.). From these 
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slides, distances from lesion involvement to each margin 
were measured. Tabulated diagnoses and distances associ-
ated with each margin of each specimen are included in Sup-
plemental File 1.
Micro‑CT image interpretation
After scans were acquired, an experienced breast radiolo-
gist (R.A.Z.) retrospectively analyzed the scans, which were 
sequentially (scan-mode) presented in two orthogonal views. 
Features such as speculated masses, distorted tissue archi-
tecture, and clustered micro-calcifications were evaluated to 
yield a binary reading of positive or negative margins. The 
radiologist was blinded to the final pathological diagnosis as 
well as the pathological diagnosis of the pre-operative nee-
dle core biopsy. For four specimens, micro-CT scans were 
compared retrospectively to de-identified single-projection 
specimen mammograms to view qualitatively the effect of 
micro-CT reconstruction on overlapping structures in the 
projection images.
Statistical methods
All statistical analyses were performed using MATLAB 
(v2016a, Mathworks, Natick, MA). For reader performance 
metrics, confidence intervals were calculated using a bino-
mial distribution. A one-sided Fisher’s exact test was used to 
calculate statistical significance between observed involve-
ment in the different surface planes.
Results
Specimen characteristics
Specimen characteristics and associated margin status are 
compiled in Table 1. For this study, a pathologically posi-
tive margin, defined as malignant or benign lesional tissue 
extending to the specimen surface, was the measured end-
point determined by histopathology. Of 32 specimens, 16% 
(5/32) had a pathologically positive margin, and of those, 
80% (4/5) were malignant (or 13%, 4/32 of all specimens). 
However, the actual re-excision rate is likely be higher as 
a close (≤ 2 mm) DCIS margin may result in re-excision 
depending on patient characteristics and physician prefer-
ence [3, 20]. In-situ cancer was more likely to be present 
with invasive cancer (13/32) than to appear on its own (3/32) 
(p < 0.005), and conversely, invasive cancer was just as likely 
to be present with in-situ disease (13/32) as to occur on its 
own (12/32) (p = 0.5).
Micro‑CT findings and comparison to single‑view 
specimen mammography
In Fig. 1, summary images for a pathologically positive 
specimen with an IDC + DCIS lesion are shown. In both 
the single-projection specimen mammogram (Fig. 1a) and 
the cross-sectional (x,y) micro-CT plane (Fig. 1b), a high 
contrast, highly speculated lesion was centrally located 
Table 1  Pathological diagnoses 
of 32 BCS specimens
DCIS Ductal carcinoma in  situ, LCIS lobular carcinoma in-situ, FCD fibrocystic disease, CSL complex 
sclerosing lesion, NAC pCR neoadjuvant chemotherapy complete pathologic response






> 0 mm and 
≤ 2 mm
Pathologically 
negative “Distant” > 
2 mm
Invasive only 12 (9,3) 1 3 8
   Ductal carcinoma 4 0 0 4
   Lobular carcinoma 4 1 0 3
   Mucinous 2 0 2 0
   Ductal and lobular 2 0 1 1
In-situ only 3 (2,1) 1 1 1
   DCIS 2 0 1 1
   Pleomorphic LCIS 1 1 0 0
Invasive + In-Situ 13 (8,5) 2 4 7
Benign 4 (4,0) 1 2 1
   FCD 1 0 1 0
   CSL 1 1 0 0
   Fibroadenoma 1 0 1 0
   NAC pCR 1 0 0 1
Total 32 (23,9) 5 10 17
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and surrounded by adipose tissue (green arrows). But in an 
orthogonal (x,z) plane (Fig. 1c), the lesion came close to the 
anterior margin (orange arrow) and touched the posterior 
margin (red arrow) 12.1 mm apart. This specimen was cor-
rectly read as positive, and highlights the ability to resolve 
lesion involvement spatially with micro-CT relative to a 
specimen radiograph. Rending of the specimen in Fig. 1d 
with the adipose tissue thresholded to be transparent reveals 
the structure of the lesion in 3D (video provided as Sup-
plemental File 2).
In Fig. 2, summary data for a pathologically negative 
specimen with an IDC + DCIS lesion are presented. A 
peripherally located, wire localized lesion with a cluster of 
micro-calcifications (orange arrows) is evident in the sin-
gle-projection specimen mammography (Fig. 2a). In cross-
sectional (x–y) micro-CT views of the specimen (Fig. 2b), 
the lesion can likewise be observed at z = 8.85 mm; how-
ever, at z = 7.50 mm, notable artifacts occur from the wire. 
In the orthogonal (x–z) plane, the lesion was read as close 
to the peripheral margin at y = 20.40 mm in agreement 
with the single-projection specimen mammogram, but at 
y = 24.60 mm the lesion is was also read as close to the deep 
posterior margin, which was not accessible in the single-
projection specimen mammogram. The micro-CT render-
ing of this specimen (Fig. 4d) resolved the 3D formation 
and organization of the micro-calcification cluster near the 
surgical clip and calcified vasculature (white arrows) (video 
provided as Supplemental File 3).
In Fig. 3a, b, summary images are presented for a speci-
men with an ILc lesion. In the single-projection specimen 
mammogram (Fig. 3a), centrally located bright, diffuse fea-
tures were present. However, in the orthorgonal micro-CT 
slices (Fig. 3b), these overlapping structures were resolved 
and revealed an adipose-glandular tissue interface. Although 
this specimen did have a pathologically positive margin but 
was read as negative, the micro-CT was able to resolve the 
overlapping tissue structures. The single-projection speci-
men mammogram for another IDC + DCIS lesion is shown 
in Fig. 3c, and the orthogonal micro-CT slices appear in 
Fig. 3d. While the lesion seemed to be centrally located in 
both the single-projection mammogram and the correspond-
ing (x–y) plane of the micro-CT, the lesion was read as posi-
tive on the anterior margin of the x–z plane. However, the 
margin was pathologically negative with the lesion 2.5 mm 
deep, and illustrates a potential limitation of micro-CT 
resulting from poor tumor to glandular tissue contrast. A 
summary of orthogonal micro-CT slices through the lesion 
of each specimen can be found as Supplemental File 4.
Comparison of micro‑CT reading to final 
pathological diagnosis
Outcomes comparing the micro-CT readings with the final 
pathological diagnoses are reported in Table 2. Of the four 
malignant specimens with a pathologically positive margin, 
two were correctly read, and of the 24 malignant specimens 
Fig. 1  a Specimen mam-
mography showing a centrally 
located IDC + DCIS lesion. b 
Reconstructed micro-CT slice 
similarly shows a centrally 
located lesion. c Orthogonal 
micro-CT slices 12.1 mm apart 
reveal a close (≤ 2 mm) anterior 
margin (orange arrow) and a 
pathologically positive deep 
margin (red arrow), which 
agreed with the final pathologic 
diagnosis. Micro-CT scale bar is 
1 cm. d 3D volume rendering of 
the specimen, with the adipose 
tissue thresholded to be trans-
parent, shows the architecture 
of the lesion and its spiculations 
(see video in Additional File 2)
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without a pathologically positive margin, 16 were correctly 
evaluated, yielding a sensitivity, specificity and accuracy 
of 50% [2/4, CI (7%–93%)], 67% [16/24, CI (45%–84%)], 
and 64% [18/28, CI (47%–81%)]. While a notable number 
of pathologically false positives occurred in the malignant 
micro-CT readings, yielding a positive predictive value of 
20% [2/10, CI (4%–44%)], the negative predictive value 
of 89% [16/18, CI (74%–96%)] was far superior. Of the 
four benign specimen readings, there was one pathologi-
cal true positive being a complex sclerosing lesion (CSL) 
and one pathological false positive being a neoadjuvant 
chemotherapy lesion with a complete pathologic response. 
These results represent an initial assessment of the imaging 
method, as micro-CT scanning of whole BCS specimens is 
still an investigative modality. The reader was briefed on the 
micro-CT system, but no official training or guidelines on 
how to interpret the micro-CT scans was available, given the 
pre-clinical nature of the technology.
Frequency of margin specific lesion involvement
The frequency of pathologically positive (0 mm), close 
(≤ 2 mm), and distant (> 2 mm) lesions for each of the six 
margins is tabulated in Fig. 4a. Six margins are listed as 
positive in total because one positive specimen had two 
separate positive margins. Similarly, a total of 25 close 
margins were found from 15 positive and close specimens. 
While, ICA + In-Situ lesions resulted in the most frequent 
number of positive and close margins for malignant lesions, 
this result is not statistically significant, and is limited by a 
small sample size. The percentage of aggregate positive and 
close lesions for each margin is plotted in Fig. 4b. Interest-
ingly, anterior and posterior margins had significantly higher 
frequency of positive and close margins (16/64) compared to 
their orthogonal margin counterparts (15/128) (p = 0.017).
Discussion
Positive surgical margins after BCS remain a notorious 
clinical challenge. Wire localization and specimen mam-
mography serve as the primary forms of intra-operative 
guidance but have led to re-excision rates ranging from 0 to 
70% [10]. Microscopic point assessment techniques, such as 
frozen-section pathology and touch prep cytology, have been 
used for directed BCS guidance with apparent diagnostic 
accuracy, but wide-spread adoption has been limited due 
to increasing labor costs of microscopic sampling over a 
macroscopic specimen [21]. Accordingly, an advantage of 
micro-CT demonstrated in this study is its ability to image 
the entire specimen in 3D, thereby enabling analyses of the 
complete specimen.
Although modest sensitivity and specificity (50%, 2/4, 
67%, 16/24) were reported in this study, significantly more 
pathologically false positives (8/28) occurred than patholog-
ically false negatives (2/28) (p = 0.04) for malignant lesions. 
While excising unnecessary tissue is less undesirable, it 
may be less harmful than a second surgical procedure. This 
Fig. 2  a Single-projection specimen mammogram revealing a periph-
erally located IDC + DCIS lesion (orange arrow). b Reconstructed 
micro-CT slices (1.35  mm apart) similarly depict the peripherally 
located mass. Notable metal reconstruction artifacts occur because of 
the localization wire. c Orthogonal micro-CT slices (4.2  mm apart) 
suggest a close peripheral margin, and also indicate a close deep mar-
gin, which would not be evident in the single-projection specimen 
mammogram. Micro-CT scale bar is 1 cm. d 3D volume rendering of 
the specimen, with the adipose tissue thresholded to be transparent, 
revealed a micro-calcification cluster, a large smooth calcification, 
tumor location metal clip, and calcified vasculature (white arrows) in 
the presentation (see video in Additional File 3)
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Fig. 3  a Single-projection 
specimen mammogram showing 
a diffuse ILc with poor contrast 
due to diffuse overlapping 
structures. b Orthogonal recon-
structed micro-CT slices resolve 
the glandular-fat interface in 
3D. Pathology confirmed the 
specimen to have a pathologi-
cally positive margin, although 
it was not detected by micro-CT 
analysis. c Single-projection 
specimen mammogram showing 
a centrally located IDC + DCIS 
lesion. d Orthogonal recon-
structed micro-CT slices 
indicate a centrally, but also 
superficially, located lesion. 
Pathology confirmed the 
lesion to be 2.5 mm from the 
superficial margin, illustrating 
that micro-CT was unable to 
resolve the tumor-connective 
tissue interface. Micro-CT scale 
bar is 1 cm
Table 2  Comparison of micro-CT reading to pathologic evaluation
PPV positive predictive value, NPV negative predictive value, Parenthesis 95% confidence intervals
All specimens (n = 32) Only malignant (n = 28)
Pathologically positive Pathologically 
negative
Total Pathologically positive Pathologically negative Total
Positive reading 3 9 12 2 8 10
Negative reading 2 18 20 2 16 18
Total 5 27 32 4 24 28
Sensitivity 60% (15%–95%) Sensitivity 50% (7%–93%)
Specificity 67% (46%–84%) Specificity 67% (45%–84%)
Accuracy 66% (47%–81%) Accuracy 64% (47%–81%)
PPV 25% (12%–45%) PPV 20% (4%–44%)
NPV 90% (75%–96%) NPV 89% (74%–96%)
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notion is highlighted by the proposed practice of undirected 
whole margin cavity shaving on all BCS procedures, which 
has recently been investigated [22]. Furthermore, single-
projection specimen mammography has reported sensitivity 
and specificity of 36% and 71% [7], whereas standard-of-
care two projection specimen mammography has yielded 
sensitivities and specificities of 54.6% and 87.8% [23], and 
more recently 58.5% and 91.8% [24]. While the preliminary 
micro-CT results presented here suggest improved sensitiv-
ity and comparable specificity to single-projection mammog-
raphy, and comparable sensitivity but inferior specificity to 
two projection mammography, a prospective, fully powered, 
head to head study of micro-CT against standard-of-care 
two projection specimen mammography is needed before 
the performances of the two modalities can be accurately 
compared. Additionally, the reading of micro-CT specimen 
scans was not optimized and no training was provided, the 
latter would benefit from an atlas of micro-CT scans of BCS 
specimens but none currently exists. The data presented here 
could serve as the starting point for a training set for the 
presentation of various pathologies in micro-CT. Neverthe-
less, reading individual cross-sectional planes of specimens 
in the projection views micro-CT appears to offer valuable 
information on lesion location.
This inceptive study provides initial evidence suggesting 
that micro-CT specimen scanning offers potential diagnos-
tic value, which could be quantified in a larger prospective 
study. While this study demonstrated the ability to detect 
in-situ disease from the analysis of clustered micro-calci-
fications, a larger sample size is needed to more reliably 
quantify the accuracy of detecting invasive versus in-situ 
disease. A notable limitation of micro-CT was its lack of 
contrast between tumor-glandular tissue, which resulted in 
poor diagnosis of tumor-glandular interfaces. While a lower 
kVp could increase image contrast, this would require a 
longer exposure time to maintain photon counts and SNR. 
Alternatively, dual energy contrast enhancement could be 
envisioned to increase contrast, but this would require two 
scans at different energies as well as the injection of a con-
trast agent [25]. Another limitation was the lack of radio-
logic training available prior to the study. In future, prospec-
tive studies, the data presented in this manuscript could be 
used as a radiologic atlas and training data set, which could 
potentially improve reader performance. Another limiting 
factor was the presence of metal streaking artifacts aris-
ing in reconstructions of specimens containing localization 
wires. In Tang et al., this difficulty was mitigated by first 
performing a single-projection image to confirm the wire 
and surgical clip were excised, then removing the wire from 
the specimen, and performing the full micro-CT scan [14]. 
However, this approach eliminates the wire and clip which 
are used regularly as lesion landmarks during subsequent 
gross analysis in Pathology. An alternative solution would 
be to implement a metal artifact reduction algorithm, such 
as segmenting the metal, manually setting its known attenu-
ation coefficient, and performing an iterative reconstruction 
[26, 27]. Finally, it should be noted that the gold-standard 
histopathological margin analysis, which samples only a 
subset of the margin chosen through gross dissection and 
evaluation, has shown to only weakly correlate with the 
actual presence of disease in the lumpectomy cavity, with 
reported accuracies as low as 64.9% and up to 20% of patho-
logically negative margins presenting residual disease [28, 
29]. This raises the possibility that micro-CT may be able to 
detect disease invisible during gross dissection and subse-
quent pathological analysis, and motives the need for more 
spatially exact correlations between micro-CT readings and 
pathological confirmation in future studies.
In summary, the results reported here demonstrate the 
feasibility of using micro-CT to provide full volume 3D 
microscopic reconstructions of lumpectomy specimens 
that highlight spatially-resolved features not evident in 
conventional 2D projection radiography. Furthermore, the 
study offers an initial measure of the correlation between 
Fig. 4  a Table summarizing the frequency of pathologically positive, 
close, and distant lesion involvement for each specific margin. b Bar 
graph of fraction of lesions ≤ 2 mm for each margin, showing a sig-
nificant increase in close anterior-posterior margins compared to the 
orthogonal margins. (16/64 ≤ 2  mm, 15/128 > 2  mm, p < 0.02). ICA 
invasive breast cancer
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micro-CT analysis of whole BCS specimens and current 
gold-standard histopathology. Micro-CT should continue 
to be investigated as a potential BCS guidance tool because 
of its rapid acquisition and volume rendering capabilities.
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